Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Breckpot, Karine" or (type any "bookEditor journalEditor issueEditor" and editor="Breckpo...

Add to list
- Journal Article
- A1
- open access
mRNA in cancer immunotherapy : beyond a source of antigen

Lien Van Hoecke (UGent) , Rein Verbeke (UGent) , Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Karim Vermaelen (UGent) , Karine Breckpot and Sandra Van Lint (UGent)

(2021) MOLECULAR CANCER. 20(1).
Add to list
- Journal Article
- A1
- open access
CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens (UGent) , Serge Muyldermans, et al.

(2021) ONCOIMMUNOLOGY. 10(1).
Add to list
- Journal Article
- A1
- open access
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.

(2021) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 22. p.172-182
Add to list
- Journal Article
- A1
- open access
Hepatocarcinoma induces a tumor necrosis factor-dependent Kupffer cell death pathway that favors its proliferation upon partial hepatectomy

Jean-François Hastir (UGent) , Sandrine Delbauve, Lionel Larbanoix, Desislava Germanova, Cleo Goyvaerts, Justine Allard, Sophie Laurent, Karine Breckpot, Alain Beschin, Martin Guilliams (UGent) , et al.

(2020) FRONTIERS IN ONCOLOGY. 10.
Add to list
- Journal Article
- A1
- open access
Anti-human PD-L1 Nanobody for immuno-PET imaging : validation of a conjugation strategy for clinical translation

Jessica Bridoux, Katrijn Broos, Quentin Lecocq, Pieterjan Debie, Charlotte Martin, Steven Ballet, Geert Raes, Sara Neyt (UGent) , Christian Vanhove (UGent) , Karine Breckpot, et al.

(2020) BIOMOLECULES. 10(10).
Add to list
- Journal Article
- A1
- open access
Broadening the message : a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Karine Breckpot, Jonas Janssens, Serge Van Calenbergh (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2019) ACS NANO. 13(2). p.1655-1669
Add to list
- Conference Paper
- C3
Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Karine Breckpot, Serge Van Calenbergh (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2018) Cancer Immunotherapy, 4th CRI-CIMT-EATI-AACR international conference, Abstracts.
Add to list
Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte (UGent) , et al.

(2018) ACS NANO. 12(10). p.9815-9829
Add to list
- Conference Paper
- C3
Co-delivery of nucleoside-modified mRNA and immunomodulators for cancer immunotherapy: restoring the immunogenicity of immunosilent mRNA

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Laura Wayteck (UGent) , Karine Breckpot, Benedicte Descamps (UGent) , Christian Vanhove (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2017) mRNA Health, 5th International conference, Abstracts.
Add to list
- Conference Paper
- C3
mRNA-based nanoparticles for therapeutic cancer vaccination

Rein Verbeke (UGent) , Laura Wayteck (UGent) , Karine Breckpot, Christian Vanhove (UGent) , Benedicte Descamps (UGent) , Stefaan De Smedt (UGent) , Heleen Dewitte (UGent) and Ine Lentacker (UGent)

(2017) mRNA therapeutics : advances and perspectives, Le Studium international conference, Abstracts.

Academic Bibliography

mRNA in cancer immunotherapy : beyond a source of antigen

CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Hepatocarcinoma induces a tumor necrosis factor-dependent Kupffer cell death pathway that favors its proliferation upon partial hepatectomy

Anti-human PD-L1 Nanobody for immuno-PET imaging : validation of a conjugation strategy for clinical translation

Broadening the message : a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells

Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy

Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Co-delivery of nucleoside-modified mRNA and immunomodulators for cancer immunotherapy: restoring the immunogenicity of immunosilent mRNA

mRNA-based nanoparticles for therapeutic cancer vaccination

Contents

Support

Contact